AQR Capital Management’s IGM Biosciences IGMS Stock Holding History

AQR Capital Management’s Portfolio IGMS Stock Details IGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-164,209	Closed	-$184K	–	3522
2025 Q2	$184K	Sell	164,209 -74,662	-31%	-$91.2K	﹤0.01%	3067
2025 Q1	$275K	Buy	+238,871	New	+$444K	﹤0.01%	2730
2024 Q3	–	Sell	-12,230	Closed	-$84K	–	2819
2024 Q2	$84K	Buy	+12,230	New	+$105K	﹤0.01%	2509
2021 Q2	–	Sell	-2,875	Closed	-$220K	–	2258
2021 Q1	$220K	Buy	+2,875	New	+$262K	﹤0.01%	2091

Other funds holding IGMS

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

AQR Capital Management's IGMS Position: Q3 2025 in Review

AQR Capital Management sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 164,209 shares — an estimated $184K sold.

AQR Capital Management first reported a position in IGMS in Q1 2021 and held it in 4 quarters. The position peaked at $275K in Q1 2025. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.

AQR Capital Management reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
AQR Capital Management sold 164,209 IGM Biosciences shares in Q3 2025, an estimated $184K.
AQR Capital Management first reported a position in IGM Biosciences in Q1 2021 and held it in 4 quarters.
AQR Capital Management's IGM Biosciences position peaked at $275K in Q1 2025.
1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.

Based on AQR Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.